Invivyd Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
IVVD$0.57-3.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
(In thousands, except share amounts)
| Common Stock · Treasury Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · TotalStockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Income (Loss) | Deficit | Equity (Deficit) | |
| Balances at December 31, 2022 | 109,044,046 | $11 | — | $— | $889,657 | $(272) | $(533,426) | $355,970 |
| Vesting of restricted common stock from early-exercised options | — | — | — | — | 1 | — | — | 1 |
| Exercise of stock options | 423,203 | — | — | — | 459 | — | — | 459 |
| Repurchase of unvested restricted common stock | (206,802) | — | 206,802 | — | — | — | — | — |
| Retirement of treasury stock | — | — | (206,802) | — | — | — | — | — |
| Stock-based compensation expense | — | — | — | — | 5,400 | — | — | 5,400 |
| Issuance of common stock under the employee stock purchase plan | 55,779 | — | — | — | 83 | — | — | 83 |
| Unrealized gain on available-for-sale securities, net of tax | — | — | — | — | — | 157 | — | 157 |
| Net loss | — | — | — | — | — | — | (35,321) | (35,321) |
| Balances at March 31, 2023 | 109,316,226 | $11 | — | $— | $895,600 | $(115) | $(568,747) | $326,749 |
| Common Stock · Treasury Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · TotalStockholders’ | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Income (Loss) · Deficit · Equity (Deficit) | |||||||||
| Balances at December 31, 2023 | 110,160,684 | $11 | — | $— | $909,539 | $(13) | $(732,069) | $177,468 | |
| Stock-based compensation expense | — | — | — | — | 5,379 | — | — | 5,379 | |
| Issuance of common stock, net of issuance costs | 9,000,000 | 1 | — | — | 39,056 | — | — | 39,057 | |
| Issuance of common stock under the employee stock purchase plan | 60,546 | — | — | — | 89 | — | — | 89 | |
| Unrealized gain on available-for-sale securities, net of tax | — | — | — | — | — | 1 | 1 | ||
| Net loss | — | — | — | — | — | — | (43,496) | (43,496) | |
| Balances at March 31, 2024 | 119,221,230 | $12 | — | $— | $954,063 | $(12) | $(775,565) | $178,498 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.